https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27917 Wed 24 May 2023 11:32:49 AEST ]]> How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55109 Wed 10 Apr 2024 08:53:58 AEST ]]> NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51319 Thu 31 Aug 2023 14:31:50 AEST ]]> Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27776 Thu 28 Oct 2021 13:04:26 AEDT ]]> Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22227 Sat 24 Mar 2018 07:17:36 AEDT ]]> A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38253 Fri 03 Sep 2021 14:46:19 AEST ]]>